Status:

UNKNOWN

Infusion of Autologous T Regulatory Cells (T Reg) at the Time of Transplantation of Allogenic Islets of Langerhans

Lead Sponsor:

The Nordic Network For Clinical Islet Transplantation

Conditions:

Type1diabetes

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Open single armed study to investigate safety and feasibility of administrating autologous T regulatory cells at the time of allogenic islet transplantation.

Detailed Description

Open single armed study to investigate safety and feasibility of administrating autologous T regulatory cells at the time of allogenic islet transplantation. Patients are recruited from the waiting li...

Eligibility Criteria

Inclusion

  • Patient must be registered on the waiting list within The Nordic Network for Clinical Islet Transplantation
  • Type 1 diabetes with diagnosed \<40years of age and with\>5 years of exogenous insulin use
  • C peptide \< 0.1 nmol/L at MMTT if no previous islet transplant
  • Adequate previous treatment by an experienced diabetologist
  • Patient must understand and be able to sign an informed consent

Exclusion

  • Patient with a previous transplant other than islets
  • Patient with an BMI\>30
  • Patient with an need of more than 1U/kg of insulin per 24h
  • Repeated abnormal liver function tests
  • non stable retinopathy
  • known abnormalities in coagulation
  • known malignancies
  • non stable heart conditions
  • active infections
  • serological proof of hepatitis B or C or HIV
  • signs of portal hypertension
  • patients that are pregnant, breast feeding or aim to become pregnant during the study period
  • patients with a PRA \> 20%, positive cross match or known DSA
  • patients with conditions that the investigator would consider unsafe to combine with islet transplantation

Key Trial Info

Start Date :

August 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2021

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT04820270

Start Date

August 20 2018

End Date

July 31 2021

Last Update

March 29 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Karolinska University Hospital

Stockholm, Sweden, 14186

2

Uppsala University Hospital

Uppsala, Sweden

Infusion of Autologous T Regulatory Cells (T Reg) at the Time of Transplantation of Allogenic Islets of Langerhans | DecenTrialz